ISSN: 0958-1669

Journal Home

Journal Guideline

Current Opinion in Biotechnology Q1 Unclaimed

Elsevier Ltd. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Opinion in Biotechnology is a journal indexed in SJR in Biotechnology and Bioengineering with an H index of 192. It has a price of 2100 €. It has an SJR impact factor of 2,819 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Bioengineering (Q1) Biomedical Engineering (Q1) Biotechnology (Q1)

Price

2100 €

Gold OA

-

Green OA

0 €

Non OA

Metrics

2,819

SJR Impact factor

192

H Index

167

Total Docs (Last Year)

469

Total Docs (3 years)

10335

Total Refs

4049

Total Cites (3 years)

435

Citable Docs (3 years)

8,84

Cites/Doc (2 years)

61,89

Ref/Doc

Aims and Scope

Other journals with similar parameters

Nature Microbiology Q1
Nano Today Q1
Nature Biomedical Engineering Q1
PLoS Medicine Q1
Ageing Research Reviews Q1

Best articles

Advances in mass spectrometry for proteome analysis

Analysis of the plant proteome

Antiangiogenic agents

Bioprocessing of therapeutic proteins

Biotechnology

Biotechnology Paper alert

BiotechnologyPaper alert

Computational methods for gene annotation: the Arabidopsis genome

Current and emerging technologies for the study of bacteria in the outdoor air

Differences among mechanisms of ribozyme-catalyzed reactions

Engineered liver for transplantation

SHOW MORE ARTICLES

Engineering the mouse genome by site-specific recombination

Expression vectors and delivery systems Food biotechnology

Extraction of pharmacophore information from high-throughput screens

Fermentation technologies for the production of probiotics with high viability and functionality

Food biotechnology

For better health and nutrition

Forest tree biotechnology

High-throughput screening of enzyme libraries

Homology-independent protein engineering

Implications of sequencing bacterial genomes for pathogenesis and vaccine development

Ligand-binding domain of estrogen receptors

Light at the end of the tunnel: from genes to function

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.